Glass House Brands (GLAS) Other Non Operating Income (2020 - 2026)
Glass House Brands' (GLAS) quarterly Other Non Operating Income came in at -$409000.0 in Q1 2026, up 29.97% on a QoQ basis from -$584000.0 in Q4 2025.
Glass House Brands (GLAS) Other Non Operating Income (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Other Non Operating Income data on file, last reported at -$409000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$409000.0 in Q1 2026; TTM through Mar 2026 was -$629000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$292000.0, changed N/A from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$409000.0, up from -$584000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for GLAS reached as high as $1128.8 billion in Q2 2023 and fell as low as -$584000.0 in Q4 2025.
- Historically, Other Non Operating Income has averaged $84.2 billion across 5 years, with a median of $42000.0 in 2022.
- Across the five-year window, Other Non Operating Income jumped 32163536.36% in 2022 and tumbled 185.38% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $48000.0 in 2022, then soared by 306.25% to $195000.0 in 2023, then surged by 250.77% to $684000.0 in 2024, then slumped by 185.38% to -$584000.0 in 2025, then climbed by 29.97% to -$409000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$409000.0 in Q1 2026, -$584000.0 in Q4 2025, and $36000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -409,000.00 |
| Dec 31, 2025 | -584,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 328,000.00 |
| Dec 31, 2024 | 684,000.00 |
| Sep 30, 2024 | -539,000.00 |
| Jun 30, 2024 | -32,000.00 |
| Dec 31, 2023 | 195,000.00 |
| Jun 30, 2023 | 1,128.84 Bn |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | 48,000.00 |
| Sep 30, 2022 | 424,010.00 |
| Jun 30, 2022 | 49.53 Bn |
| Mar 31, 2022 | 16,105.00 |
| Dec 31, 2021 | 707,784.00 |
| Sep 30, 2021 | 3.13 Mn |
| Jun 30, 2021 | 154,000.00 |
| Mar 31, 2021 | 6,024.00 |
| Dec 31, 2020 | -1.67 Mn |
| Sep 30, 2020 | 988,898.00 |